- Home
- GEHC vs VTR Comparison
GEHC vs VTR Comparison
Compare GEHC & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEHC
- VTR
- Stock Information
- Founded
- GEHC 1892
- VTR 1983
- Country
- GEHC United States
- VTR United States
- Employees
- GEHC N/A
- VTR N/A
- Industry
- GEHC Computer Software: Prepackaged Software
- VTR Real Estate Investment Trusts
- Sector
- GEHC Technology
- VTR Real Estate
- Exchange
- GEHC Nasdaq
- VTR Nasdaq
- Market Cap
- GEHC 32.5B
- VTR 28.6B
- IPO Year
- GEHC N/A
- VTR 1998
- Fundamental
- Price
- GEHC $71.28
- VTR $62.63
- Analyst Decision
- GEHC Strong Buy
- VTR Buy
- Analyst Count
- GEHC 10
- VTR 9
- Target Price
- GEHC $88.80
- VTR $72.78
- AVG Volume (30 Days)
- GEHC 2.9M
- VTR 3.0M
- Earning Date
- GEHC 07-30-2025
- VTR 07-31-2025
- Dividend Yield
- GEHC 0.20%
- VTR 3.06%
- EPS Growth
- GEHC 38.77
- VTR N/A
- EPS
- GEHC 4.76
- VTR 0.33
- Revenue
- GEHC $19,799,000,000.00
- VTR $5,055,949,000.00
- Revenue This Year
- GEHC $5.19
- VTR $13.97
- Revenue Next Year
- GEHC $4.70
- VTR $8.69
- P/E Ratio
- GEHC $14.97
- VTR $191.27
- Revenue Growth
- GEHC 1.56
- VTR 10.36
- 52 Week Low
- GEHC $57.65
- VTR $49.48
- 52 Week High
- GEHC $94.80
- VTR $71.36
- Technical
- Relative Strength Index (RSI)
- GEHC 48.88
- VTR 39.16
- Support Level
- GEHC $70.90
- VTR $62.59
- Resistance Level
- GEHC $73.12
- VTR $64.32
- Average True Range (ATR)
- GEHC 1.38
- VTR 1.02
- MACD
- GEHC -0.09
- VTR 0.02
- Stochastic Oscillator
- GEHC 40.62
- VTR 18.06
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.